Abbott Laboratories Stock

$131.67

0.69% today

NYSE, Aug 25, 04:46 pm CET

ISIN

US0028241000

Symbol

ABT

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts News Strategies

Abbott Laboratories Stock price

$132.59

+31.20 30.77% 5Y

NYSE, Closing price Fri, Aug 22 2025

+0.59 0.45%

ISIN

US0028241000

Symbol

ABT

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Key metrics

Basic

Market capitalization

$230.8b

Enterprise Value

$236.9b

Net debt

$6.2b

Cash

$7.3b

Shares outstanding

1.7b

Valuation (TTM | estimate)

P/E

16.6 | 25.5

P/S

5.4 | 5.1

EV/Sales

5.5 | 5.2

EV/FCF

35.0

P/B

4.6

Dividends

DPS

$2.24

Yield 1Y | 5Y

1.7% | 1.8%

Growth 1Y | 5Y

7.7% | 11.2%

Payout 1Y | 3Y

29.2% | 42.0%

Increased

11 Years

Financials (TTM | estimate)

Revenue

$43.1b | $45.1b

EBITDA

$9.5b | $12.0b

EBIT

$7.7b | $10.5b

Net Income

$14.0b | $9.0b

Free Cash Flow

$6.8b

Growth (TTM | estimate)

Revenue

5.9% | 7.6%

EBITDA

9.1% | 35.6%

EBIT

13.8% | 50.6%

Net Income

151.6% | -32.5%

Free Cash Flow

19.8%

Financial Health

Equity Ratio

58.6%

Return on Equity

28.1%

ROCE

10.9%

ROIC

19.2%

Debt/Equity

0.3

EPS

$8.0

FCF per Share

$3.9

Short interest

1.1%

Employees

114k

Rev per Employee

$370.0k

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Get Started for Free Today

Abbott Laboratories Stock Analysis

Unlock Scores for Free

??

35 Analysts have issued a Abbott Laboratories forecast:

23x Buy

66%

12x Hold

34%

More details on Analyst Estimates Including Price Targets

35 Analysts have issued a Abbott Laboratories forecast:

Buy

66%

Hold

34%

Analyst Estimates with Stock Price Targets

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	43,109 43,109	6% 6% 100%
- Direct Costs	18,882 18,882	4% 4% 44%
Gross Profit	24,227 24,227	7% 7% 56%
- Selling and Administrative Expenses	11,918 11,918	6% 6% 28%
- Research and Development Expense	2,837 2,837	9% 9% 7%
EBITDA	9,472 9,472	9% 9% 22%
- Depreciation and Amortization	1,775 1,775	8% 8% 4%
EBIT (Operating Income) EBIT	7,697 7,697	14% 14% 18%
Net Profit	13,979 13,979	152% 152% 32%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Abbott Laboratories Stock News

Positive

Seeking Alpha

●

about 13 hours ago

Best Dividend Kings: August 2025

Dividend Kings underperformed SPY year-to-date but are showing stronger gains in August, with several stocks achieving double-digit returns in 2025. Fifteen Dividend Kings currently appear undervalued with expected long-term annualized returns of at least 10%, based on Dividend Yield Theory analysis. Recent dividend increases have modestly boosted the group's 2025 dividend growth rate, though i...

Positive

The Motley Fool

●

2 days ago

3 Unstoppable Dividend Stocks to Buy Right Now

How does getting paid to own a stock sound to you? That's exactly what dividends do.

Neutral

PRNewsWire

●

7 days ago

Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season

All 18 Big Ten universities will go head-to-head in Year 2 of the nationwide challenge, the 'We Give Blood' drive, to inspire the most blood donations from students, alumni, and fans with the winning school earning $1 million from Abbott for student or community health Abbott is releasing exclusive, limited-edition Homefield designed T-shirts for each Big Ten school. Be among the first to recei...

More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office	United States
CEO	Robert Ford
Employees	114,000
Founded	1888
Website	www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now